• Explore /
  • Poster
  • / Infections and their impact on patients on pembrolizumab-based therapies for head and neck cancer.

Infections and their impact on patients on pembrolizumab-based therapies for head and neck cancer.

Abstract Poster

Authors

null

Yuqi Zhang

Houston Methodist Hospital, Houston, TX

Yuqi Zhang , Jiaqiong Xu , Ibrahim Muhsen , Ethan Burns , Shivan M Shah , Godsfavour Umoru , Charisma Mylavarapu , Kai Sun , Aubrey Crenshaw , Abdullah Esmail , Ryan Blair Kieser , Carlo Guerrero , Zimu Gong , Kelly Gee , Kirk Heyne , Monisha Singh , Jun Zhang , Maen Abdelrahim

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Head and Neck Cancer

Track

Head and Neck Cancer

Sub Track

Advanced/Metastatic Disease

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 6035)

DOI

10.1200/JCO.2022.40.16_suppl.6035

Abstract #

6035

Poster Bd #

27

Abstract Disclosures

Similar Posters

First Author: Payman Ghasemi Saghand

First Author: David Lynn

First Author: Karim Amrane Sr.

First Author: Chloe Lim